112 related articles for article (PubMed ID: 2647891)
21. Autoimmune-mediated vasculopathy.
Chen W; Thoburn CJ; Miura Y; Sommer M; Hruban R; Qian Z; Baldwin W; Hess AD
Clin Immunol; 2001 Jul; 100(1):57-70. PubMed ID: 11414746
[TBL] [Abstract][Full Text] [Related]
22. Effect of post-transplant methotrexate, cyclosporin A and prednisolone on graft rejection after allogeneic bone marrow transplantation.
Uharek L; Gassmann W; Fleischhauer D; Wottge HU; Loeffler H; Mueller-Ruchholtz W
Bone Marrow Transplant; 1991 Jan; 7(1):17-22. PubMed ID: 2043873
[TBL] [Abstract][Full Text] [Related]
23. Induction of syngeneic graft-versus-host disease in LPS hyporesponsive C3H/HeJ mice.
Flanagan DL; Gross R; Jennings CD; Caywood BE; Goes S; Kaplan AM; Bryson JS
J Leukoc Biol; 2001 Dec; 70(6):873-80. PubMed ID: 11739549
[TBL] [Abstract][Full Text] [Related]
24. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
Flanagan DL; Jennings CD; Bryson JS
J Immunol; 1999 Aug; 163(3):1170-7. PubMed ID: 10415011
[TBL] [Abstract][Full Text] [Related]
25. Murine syngeneic graft-versus-host disease is responsive to broad-spectrum antibiotic therapy.
Brandon JA; Jennings CD; Kaplan AM; Bryson JS
J Immunol; 2011 Mar; 186(6):3726-34. PubMed ID: 21296982
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin A-induced autoimmune disease in mice.
Bucy RP; Xu XY; Li J; Huang G
J Immunol; 1993 Jul; 151(2):1039-50. PubMed ID: 8335890
[TBL] [Abstract][Full Text] [Related]
27. Anti-IL-23p19 therapy inhibits the adoptive transfer of syngeneic graft-versus-host disease.
Brandon JA; Jennings CD; Kaplan AM; Bryson JS
Cytokine; 2013 Mar; 61(3):732-5. PubMed ID: 23402791
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility to cyclosporin A-induced autoimmunity: strain differences in relation to autoregulatory T cells.
Barendrecht MM; Tervaert JW; van Breda Vriesman PJ; Damoiseaux JG
J Autoimmun; 2002 Feb; 18(1):39-48. PubMed ID: 11869045
[TBL] [Abstract][Full Text] [Related]
29. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
Thoburn CJ; Miura Y; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Sep; 10(9):591-603. PubMed ID: 15319771
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation.
Hess AD; Vogelsang GB; Heyd J; Beschorner WE
Transplant Proc; 1987 Feb; 19(1 Pt 3):2683-6. PubMed ID: 3547947
[No Abstract] [Full Text] [Related]
31. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
Chen W; Thoburn C; Hess AD
J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
[TBL] [Abstract][Full Text] [Related]
32. Development of a T(H)17 immune response during the induction of murine syngeneic graft-versus-host disease.
Brandon JA; Jennings CD; Kaplan AM; Bryson JS
Cytokine; 2010 Dec; 52(3):265-73. PubMed ID: 20833063
[TBL] [Abstract][Full Text] [Related]
33. Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
Hess AD; Vogelsang GB; Silanskis M; Friedman KA; Beschorner WE; Santos GW
Transplant Proc; 1988 Jun; 20(3 Suppl 3):487-92. PubMed ID: 3291285
[No Abstract] [Full Text] [Related]
34. Autoantibodies in cyclosporine A-induced autoimmune disease.
Wodzig KW; Majoor GD; van de Gaar MJ; van Breda Vriesman PJ
Transplant Proc; 1990 Dec; 22(6):2586-7. PubMed ID: 2264163
[No Abstract] [Full Text] [Related]
35. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
Hess AD; Horwitz LR; Laulis MK
Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
[No Abstract] [Full Text] [Related]
36. The induction of graft versus host disease in mice treated with cyclophosphamide.
Owens AH; Santos GW
J Exp Med; 1968 Aug; 128(2):277-91. PubMed ID: 4873022
[TBL] [Abstract][Full Text] [Related]
37. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility and resistance to cyclosporin A-induced autoimmunity in rats.
Wodzig KW; Majoor GD; Van Breda Vriesman PJ
Autoimmunity; 1993; 16(1):29-37. PubMed ID: 8136464
[TBL] [Abstract][Full Text] [Related]
39. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
40. Relationship of cyclosporine A-mediated inhibition of clonal deletion and development of syngeneic graft-versus-host disease.
Bryson JS; Caywood BE; Kaplan AM
J Immunol; 1991 Jul; 147(2):391-7. PubMed ID: 2071889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
